Duke, E. S., Bradford, D., Sinha, A. K., Li, X., Mishra-Kalyani, P. S., Claro, R. A. D., Larkins, E., Drezner, N. (2026). Selpercatinib and the Crossover Conundrum: Potential Impact of Postprogression Therapies on Overall Survival. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02375